Dejan Pavlovic

Dejan Pavlovic is an experienced medical professional with a robust background in pharmacovigilance and drug safety. Currently serving as Executive Medical Director at Xenon Pharmaceuticals Inc. since November 2024, Dejan previously held significant roles at AstraZeneca, including Executive Director and Senior Medical Director in Patient Safety for the Oncology therapeutic area from October 2015 to November 2024. Prior experience also includes Medical Director of Patient Safety at MedImmune and various positions at UCB Biosciences and UCB, where Dejan was involved in drug safety and pharmacovigilance. Academically, Dejan holds a PhD in Medicine from Vrije Universiteit Brussel, a Master in Industrial Management from EHSAL Business School, and another Master in Medical and Pharmaceutical Research from Vrije Universiteit Brussel, complemented by an MD from Univerzitet u Nišu.